Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

Published:2009-11-06 Issue:1 Volume:53 Page:1-6
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Butler P. C.,Matveyenko A. V.,Dry S.,Bhushan A.,Elashoff R.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-009-1591-5.pdf

Reference38 articles.

1. Nachnani JS, Bulchandani DG, Nookala A et al (2009) Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia. doi: 10.1007/s00125-009-1515-4

2. Cure P, Pileggi A, Alejandro R (2008) Exenatide and rare adverse events. N Engl J Med 358:1969–1970; discussion 1971-1962

3. Noel RA, Braun DK, Patterson RE, Bloomgren GL (2009) Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care 32:834–838

4. Dore DD, Seeger JD, Arnold Chan K (2009) Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin 25:1019–1027

5. Koehler JA, Baggio LL, Lamont BJ, Ali S, Drucker DJ (2009) Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 58:2148–2161

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues;Peptides;2024-08

2. Depression and Associated Risk Factors Among Type 2 Diabetic Patients: A Cross Sectional Study on a Convenience Sample from the Diabetic Center, Khamis Mushait; Saudi Arabia;Neuropsychiatric Disease and Treatment;2022-08

3. Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity;ACS Pharmacology & Translational Science;2019-08-20

4. Fighting Type-2 Diabetes: Present and Future Perspectives;Current Medicinal Chemistry;2019-06-20

5. Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies;Diabetes, Obesity and Metabolism;2016-09-26